DLX-105
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
DLX-105
Target :
Interleukin|||TNF|||IFNARRelated Pathways :
Apoptosis|||Immunology/InflammationBioactivity :
DLX-105 is a human monoclonal antibody (mAb) that targets TNFSF2/TNFa. It reduces epidermal thickness and the expression of K16 and Ki67 in the skin. Additionally, DLX-105 downregulates mRNA levels of IL-17, TNF-?, IL-23p19, IL-12p40, and IFN-?. This compound is useful for psoriasis research.Shipping Conditions :
Cool packStorage Temperature :
-20°C
